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Abstract
Objectives: Antibiotic resistance (ABR) particularly hits resource poor countries, and is fuelled by irrational antibiotic (AB)
prescribing. We surveyed knowledge, attitudes and practices of AB prescribing among medical students and doctors in
Kisangani, DR Congo.
Methods: Self-administered questionnaires.
Results: A total of 184 questionnaires were completed (response rate 94.4%). Knowledge about AB was low (mean score
4.9/8 points), as was the estimation of local resistance rates of S. Typhi and Klebsiella spp.(correct by 42.5% and 6.9% of
respondents respectively). ABR was recognized as a problem though less in their own practice (67.4%) than nation- or
worldwide (92.9% and 85.5%, p,.0001). Confidence in AB prescribing was high (88.6%) and students consulted more
frequently colleagues than medical doctors when prescribing (25.4% versus 11.6%, p = 0.19). Sources of AB prescribing
included pharmaceutical companies (73.9%), antibiotic guidelines (66.3%), university courses (63.6%), internet-sites (45.7%)
and WHO guidelines (26.6%). Only 30.4% and 16.3% respondents perceived AB procured through the central procurement
and local pharmacies as of good quality. Local AB guidelines and courses about AB prescribing are welcomed (73.4% and
98.8% respectively).
Conclusions: This data shows the need for interventions that support rational AB prescribing.
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Introduction
Increasing resistance of bacterial pathogens to commonly used
antibiotics (AB) has become a world-wide public health concern
[1]. Spread of antibiotic resistance (ABR) is causing not only
increased morbidity and mortality but also a high economic
burden. Health systems in low income countries which are already
struggling with chronic underfunding and weak institutional
structures are particularly hit by ABR [1].
The causes that drive ABR in low income countries are well
known. The main factors are irrational drug use such as over-
prescription and unnecessary prescription of AB (such as for viral
infections), incomplete treatments and self-medication as well as
insufficient infection control measures to prevent spread of
resistant bacteria both in the community and the hospital [2].
The prescribing behavior of medical doctors plays a key role in the
consumption of AB and is a potential tool for control and
containment of ABR. Factors thriving prescribing behavior of
medical doctors can be analyzed by so-called KAP-surveys, in
which knowledge (K), attitudes (A) and practices (P) of prescribers
are assessed. In addition, medical students are an important target
group for sustainable AB prescribing intervention programs [3].
There is only little KAP-information among prescribers in
hospital settings [4,5,6,7,8,9] compared to a wider variety of
publications reporting from community settings. In addition, the
available studies have all been conducted in high (Europe, U.S.) or
middle (Brazil, Peru) income countries. We therefore conducted a
KAP-survey about AB prescribing among last year medical
students and medical doctors in a low income setting in Central
Africa.
Methods
Study Design and Setting
The survey was conducted during March – April 2011 in the
area of Kisangani, a town of 600,000 inhabitants in the Oriental
Province, in the center of Democratic Republic of the Congo
(DRC) (Figure 1). Kisangani comprises a health district with five
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health zones. In addition to the public health centers (one for each
health zone), there are numerous private and confessional health
centers in the area.
The University Hospital of Kisangani (UH Kisangani) is a 129-
bed referral and teaching hospital accommodating students of the
Faculty of Medicine of the University of Kisangani for clinical
clerkships. Despite on top of the health pyramid, UH Kisangani is
only basically equipped as a consequence of recent wars and a
degraded economic situation. There are no functioning microbi-
ology services and no antibiotic committee. Bed occupancy rate in
2011 was estimated at 45.5% (UK Kisangani, annual report 2011).
The other health centers and the two referral hospitals in
Kisangani have similar constraints of infrastructure and equip-
ment.
Respondents
This study was performed as a cross-sectional survey with
purposeful sampling among last year medical students (who are
prescribing as part of their practice) as well as prescribing medical
doctors with different extent of work experience. The survey was a
self-administered questionnaire which was distributed and col-
lected by trained collaborators (co-authors Y.K. and B.B.).
Last year medical students were recruited at UH Kisangani
(total number of students was 131). Prescribing medical doctors
were visited on-site at the hospitals or health centers after having
made an appointment. Medical doctors working in the adminis-
trative services were not addressed. According to the Provincial
Health Division, the total number of prescribing medical doctors
in Kisangani in 2011 was estimated at 185 (personal communi-
cation).
The surveys were given to the respondents who filled in the
forms immediately. During completion, the collaborator was
available for explanation. The filled-in copies were handed over
immediately after completion. No incentives were given to the
respondents.
Survey Instrument
The survey instrument was developed according to a previous
questionnaire used in Peru [9], and adapted to the setting in
Kisangani. Translation from the original Spanish version into
French was performed by one of the authors (J.J.)and two local
experts (B.B. and J.A.) carefully reviewed the translation for
compliance of phrasing and wording with local French and
professional language. Prior to release, the survey was validated for
content and relevance by a team of four professionals (D.N., A.J.,
H.D and B.B).
The original questionnaire was amended with questions
addressing the resources about AB prescribing (including phar-
maceutical companies), the perceptions of the causes of ABR and
the quality of locally available AB (one question each). The final
survey consisted of 33 questions (Table S1). Three questions
addressed work experience and prescription patterns (n = 3),
awareness on the current scope of ABR (n = 5), the respondents’
confidence in AB prescribing and willingness to seek input from
superiors or peers (n = 3). In addition, information was collected
about the sources of information used and continuing education
about AB prescribing (n = 2 subdivided questions ) and about
Figure 1. Map of the study site.
doi:10.1371/journal.pone.0055495.g001
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factors influencing the decision about AB prescribing (n = 7).
Acceptability and appropriateness of potential interventions were
assessed with another three questions (n = 3). Finally, knowledge
was assessed in a total of eight questions (n = 8), divided in three
case presentations and five questions about AB properties. A
knowledge score was calculated as the sum of correct answers to
these questions. Two additional knowledge questions addressed
the respondents’ estimations of local resistance rates of two key-
pathogens (n = 2), but where not included in the overall score.
Ethical Considerations
Pending the installation of an ethical committee in the Oriental
Province and at the UH Kisangani, the study was assessed and
approved by the Provincial Health Officer and the Director’s
Board of UH Kisangani, the highest possible authority. All data
was analyzed anonymously.
Data Registration and Statistical Analyses
Data were anonymously entered in an Excel database
(Microsoft Corporation, Redmond, Washington, USA). Propor-
tions and means were calculated for categorical and continuous
variables respectively. Chi square, Fisher’s exact test and Mann-
Whitney U test were performed as appropriate to calculate a 95%
level of significance. All statistical analyses was performed using
STATA version 12 (Statacorp Texas, USA).
Results
Baseline Data: Coverage, Response Rate, Professional
Profile
Eighty-nine of the estimated 185 medical doctors in Kisangani
were addressed, as well 106 of the 131 medical students at UH
Kisangani (coverage rates of 48.1% and 80.9% respectively). Of
the total of 195 questionnaires, 11 (5.6%) were either not returned
or incompletely filled in (all from medical doctors), leaving 184
eligible surveys (response rate 94.4%). Medical doctors and
students accounted for 78 (42.3%) and 106 (57.6%) of respondents
respectively.
Among the medical doctors, 11.5% (n = 9) had less than one
year work experience, 38.5% (n = 30) had between 1 and 3 year
work experience, 23.1% (n = 18) between 4 to 6 years work
experience and the remaining 26.9% (n = 21) had more than 10
years of work record. Unless otherwise stated, the results are
presented for all respondents (medical students and medical
doctors regardless of work experience) combined, except when
there were differences between these groups.
All respondents prescribed AB to in- as well as outpatients.
More than half (100/183, 54.4% - one respondent did not reply to
this question) reported to prescribe AB more than once a day,
15.2% (n = 28) and 17.4% (n = 32) reported 1 to 2 times and 3 to
5 times per week respectively. As expected, medical students
prescribed less frequently compared to medical doctors ($1
prescription/day: 42.5% versus 85.7% and ,1 prescription/day:
57.5% versus 14.3%; p,.0001).
Knowledge
On a score of 8, the mean (6 S.D.) and median (range) scores
were 4.9 (60.09) and 5 (2–8) respectively. A total of 1 (0.5%) and
20 (10.9%) of respondents scored 8 and 7 points respectively;
scores of 6 and 5 were achieved by 36 (19.6%) and 55 (29.9%)
respondents respectively. The remaining respondents (n = 72,
39.1%) had a score of 4 or less. There was no significant difference
in the mean score according to years of experience (p = .19),
frequency of consulting colleagues before deciding about AB
prescribing (p = .21) or previous training about AB prescribing (p
= .54).
As to the individual questions (Table 1), the results were as
follows: although the majority (89.7%) of respondents correctly
answered to install no AB treatment in case of non-febrile
diarrhea, less than one third (27.9%) replied so to the question
about upper respiratory tract infection (URTI). Further, less than
20% of respondents correctly replied to questions about dose
reduction in case of renal failure and less than 40% about cross-
resistance of methicillin resistant Staphylococcus aureus (MRSA) to
beta-lactam AB. Compared to medical doctors, medical students
answered three questions significantly more frequently incorrect:
they more frequently advised AB in case of URTI, were less aware
of the cross-resistance of MRSA and were more unsure about safe
antibiotics in pregnancy.
Less than half and fewer than 10% of respondents correctly
estimated the local resistance rate of, Salmonella Typhi to
trimethoprim-sulphamethoxazole (cotrimoxazole, TMP/SMX)
and of Klebsiella spp. to ceftriaxone respectively [10,11]. The other
respondents invariably underestimated the resistance rates of both
pathogens.
Awareness
The majority of respondents agreed or strongly agreed that
ABR is an important problem, though significantly (p,.0001) less
in their own practice as compared to the national or worldwide
scope (Table 2). Likewise, most (87.5%) respondents agreed that
AB are overused in the country. Factors recognized by respon-
dents as thriving ABR in DRC are listed in Table 3: self-treatment
by patients, and non-completing AB treatment were scored by
approximately 90% of respondents, but only 69.0% and 71.2%
respectively agreed with over-prescription and low quality of AB
and less than two-thirds (64.1%) with in-hospital transmission of
AB resistant bacteria as thriving factors.
Confidence and Seeking Input
Nearly 90% of the respondents declared to feel very confident
(n = 21, 11.4%) or confident (n = 142, 77.2%) about their
knowledge on AB. Medical students tended to have lower self-
confidence in AB prescribing than medical doctors (85.7% versus
94.8%), although this difference did not reach statistical difference
(p = .053).There was no significant correlation between confidence
and mean knowledge score (p = .1622). Despite this confidence,
more than half (55.4%) of respondents agreed with the statement
that the selection of the correct AB is difficult. However, when
asked about the frequency of consulting a colleague when
prescribing AB, most respondents replied sometimes (79.4%) and
never (1.1%) versus 3.3%, 11.4% and 4.0% replying half of the
times, mostly and always respectively. In line with the lower self
confidence among student they also reported to consult signifi-
cantly more often a colleague compared to medical doctors (25.4%
versus 11.6%; p= .019).
Source of Information
For medical doctors and students combined, the sources of
information about AB used during the month prior to the survey
were, in rank of decreasing frequency: pharmaceutical companies
(consulted by 73.9% of respondents), antibiotic guidelines (66.3%),
university courses (63.6%) and information retrieved from the
internet (45.7%). Only 26.6% of respondents declared to have
used WHO guidelines. Table 4 gives the details for medical
doctors versus students: university courses had been used
significantly more by students and there were more medical
doctors who had consulted internet sources, although this
Antibiotic Prescribing in DR Congo: A KAP Survey
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Table 1. Knowledge questions and results.
No. Question and possible answers (correct answer in bold)
Overall N
(%)
answered
correctly*
N (%) of
doctors
answered
correctly*
N (%) of
students
answered
correctly* p
1 A 4-year-old girl has diarrhea for 4 days (3 stools/day). She has no fever at examination nor during
the last few days. Which treatment do you propose?
a) amoxicillin p.o. 165/184 68/78 97/106 0.340
b) TMP/SMX**p.o. (89.7%) (85.9%) (74.5%)
c) amoxicillin-clavulanic acid p.o.
d) no antibiotic treatment, only oral rehydration
2 A 6-year-old child has a fever of 38uC, purulent rhinitis and angina for two days. At inspection,
the throat is reddish. Which treatment do you recommend?
a) TMP/SMX** p.o. 51/183 28/78 23/105 0.038
b) amoxicillin p.o. (27.9%) (35.9%) (21.9%)
c) amoxicillin-clavulanic acid p.o.
d) no antibiotic
3 During your ward round, you see two patients with severe renal failure. Patient A is a 68-year-old man
suffering from serious cellulitis at the leg, he is treated with clindamycin. Patient B is a 64-year-old
diabetic woman which is blindly (empirically) treated for septicemia with ceftriaxone. Dosage reduction
is needed for:
a) Patient A 34/183 12/77 22/106 0.375
b) Patient B (18.6%) (15.6%) (20.7%)
c) both patients
d) in neither patient A nor patient B
4 Which one of the following antibiotics is safe during pregnancy?
a) amoxicillin 170/183 76/78 94/105 0.039
b) ciprofloxacin (92.9%) (97.4%) (89.5%)
c) gentamicin
5 Which one of the following antibiotics has the best activity against anaerobes?
a) ciprofloxacin 171/182 72/77 99/105 0.827
b) metronidazole (94.0%) (93.5%) (94.3%)
c) cotrimoxazole
6 Methicillin resistant - Staphylococcus aureus is susceptible to:
a) amoxicillin-clavulanic acid 64/174 33/73 31/101 0.0500
b) cefotaxime (36.8%) (45.2%) (30.7%)
c) ceftriaxone
d) none of those antibiotics
7 Which one of the following antibiotic most effectively crosses the blood-brain barrier?
a) clindamycin 132/179 58/75 74/104 0.354
b) ceftriaxone (73.7%) (77.3%) (71.1%)
c)vancomycin
8 Aminoglycosides such as gentamicin are very active if they are administered as follows :
a) orally three times daily 109/179 44/74 65/105 0.741
b) parenteral once daily (60.9%) (59.5%) (61.9%)
c) parenteral three times daily
9 In DR Congo, what is according to your information the estimated resistance rate of Salmonella Typhi to
Cotrimoxazole (Bactrim)?
a) 0–10% 76/179 32/75 44/104 0.962
b) 10–20% (42.5%) (42.7%) (42.3%)
c) 25–50%
d) 50–75%
10 In DR Congo, what is according to your information the estimated resistance rate of Klebsiella to Ceftriaxone?
a) 0–10% 12/173 3/70 9/103 0.258
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difference did not reach statistical significance. With regard to
appreciation of usefulness, all sources were appreciated as useful or
very useful by more than 85% of respondents, except for the
information provided by pharmaceutical companies (75.5%).
Factors Influencing Prescription
Patient pressure was perceived as a factor contributing to
overuse of AB in the community by nearly two-thirds (61.9%) of
respondents, whereas only one third (34.3%) did so for the hospital
setting (p,.001). The majority of respondents (n = 165; 89.7%)
agreed that knowledge of local AB resistance patterns was needed
for good prescribing. About two-thirds (63.8%) of respondents did
not agree with the statement that choice of prescribed AB was
more influenced by availability than by the cause of infection. A
total of 72.3% of respondents disagreed with the statement that
ABs if not needed do not cause harm to the patient; however,
6.0% were neutral and about one fifth (21.7%) subscribed this
statement.
Only 16.3% (n= 30) of respondents agreed that ABs available at
the local pharmacies were in most cases of good quality (39.7%
mentioned they did not have an opinion about it). One third
(30.4%) believed that AB coming through the national central
procurement office were of good quality (i.e. significantly higher
than those available at the pharmacies; p,.001), whereas 22.8%
considered them to be of poor quality and nearly half (44.6%) of
respondents did not indicate an opinion.
Acceptability of Potential Interventions
Nearly three quarters (73.4%) of respondents agreed with the
statement that local AB guidelines were more useful than
international guidelines. AB committees were only seen by 9.8%
of respondents as obstacles rather than as a help, although 42.9%
of respondents declared not to have an opinion about this topic.
Nearly all (98.8%) respondents expressed their wish for additional
training on AB prescribing.
Discussion
Limitations and Strengths
KAP-surveys provide insights in the driving forces of AB
prescribing and are complementary to surveillance of AB
resistance and AB consumption which together constitute baseline
information to design interventions about AB prescribing [1].
KAP-surveys however have inherent limitations: for instance,
respondents may be triggered to the topic and this - in
combination with the multiple choice format of the questionnaire
- may direct them to socially desirable answers. Further, expecting
a professional in a remote and busy health center to fill in a
questionnaire is not evident. Finally, the present survey only
addressed medical doctors and students, whereas in practice also
nursing staff and traditional healers prescribe ABs in DRC.
To counter these limitations, the present survey was validated
by a team of local professionals and took into account limitation in
time and concentration of the respondents. In order to avoid
influence on answers regarding attitudes and practice questions
assessing knowledge were presented at the end of the question-
naire. In order to minimize professional pressure, students were
individually addressed by one of their peers (Y.K.). In addition, the
questionnaire was distributed and filled-in on-site, precluding
consultancy of peers or resources.
Among the strengths of the present KAP-survey was the fact
that it addressed most of the topics cited by WHO as influencing
AB prescribing, except for economic incentives and workload [1].
By addressing the respondents in an active way, the coverage and
response rates were high. Finally, to the best of our knowledge, this
is the first survey conducted in a low income country which faces
Table 1. Cont.
No. Question and possible answers (correct answer in bold)
Overall N
(%)
answered
correctly*
N (%) of
doctors
answered
correctly*
N (%) of
students
answered
correctly* p
b) 10–20% (6.9%) (4.3%) (8.7%)
c) 25–50%
d) 50–75%
*only questions 1–8 were included in the score;
**trimethoprim/sulphamethoxazole.
doi:10.1371/journal.pone.0055495.t001
Table 2. Perception of Antibiotic resistance as a problem.
Antibiotic resistance is a problem World wide In DRC In my practice
n (%) n (%) n (%)
strongly agree 91 (49.5%) 115 (62.5%) 55 (29.9%)
agree 66 (35.9%) 56 (30.4%) 69 (37.5%)
neutral 16 (8.7%) 8 (4.4%) 20 (10.9%)
do not agree 4 (2.2%) 2 (1.1%) 26 (14.1%)
do not at all agree 6 (3.3%) 3 (1.6%) 13 (7.1%)
no answer 1 (0.5%) 0 (0%) 1 (0.5%)
doi:10.1371/journal.pone.0055495.t002
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both virtual absence of microbiological facilities and a poor access
to quality medicines [12].
Knowledge
The overall mean score on the knowledge questions (4.9/8
points) was lower than the result from the similar survey
conducted in Peru [9] (6.0/7 points). This difference was in
large part attributable to the three questions that were worst
replied, i.e. the questions about AB use in URTI, cross-
resistance of MRSA to beta-lactam and AB dose reduction in
renal failure. Among the indicators of AB prescribing patterns,
WHO has listed the proportions of cases of diarrhea and URTI
treated with AB [1]. According to a compilation of community-
based studies, the proportion of patients inappropriately
receiving AB in both conditions vary between 40–60%
[1].Taken into account the present proportion of incorrect
answer to the case of URTI (more than two-thirds of
respondents would initiate AB treatment) it is clear that this
topic is a target for future intervention. Likewise it is striking
that nearly two-thirds of respondents did not know about the
cross-resistance of MRSA to beta-lactam AB. In part, this may
be explained by the absence of microbiological facilities in DR
Congo precluding estimates of MRSA incidence [13].
Further, there was insufficient knowledge about local AB
resistance rates of Salmonella Typhi and Klebsiella spp. Although
this is not unexpected in a setting with few microbiological
facilities, similar findings were observed in the setting in Peru [9]
and also in industrialized countries [4].
Awareness
Similar to previous surveys [5,6,8], ABR as a public health
problem was found to be highly recognized at the global and
national level but less in their own hospital. Among the factors
fuelling ABR, patient-related issues (self-medication, not complet-
ing treatment) were recognized more frequently as compared to
prescriber-related items such as over-prescription. The fact that
less than two-thirds of respondents recognized the role of in-
hospital spread of AB resistant bacteria is of concern and point to a
potential topic of training and sensibilization.
Confidence and Seeking Input
Despite the fact that more than half of respondents agreed that
it is difficult to choose the correct AB, there was high self-
confidence in AB prescribing which seemingly contrasted to the
modest knowledge scores. Likewise, there was a low propensity to
consult colleagues when prescribing AB. Medical students tended
to be less self-confident and were more willing to seek input of
colleagues. Similar difference in attitudes have been observed
between residents (doctors in training) and medical doctors and
these observations confirm medical students and junior doctors as
a feasible target group for future interventions in AB prescribing
[3,8,9].
Source of Information
The availability of unbiased information about AB is a
prerequisite for appropriate AB prescribing [1]. For the present
setting, several observations were made. First, information from
pharmaceutical companies ranked highest in accessibility. Al-
though lowest appreciated for usefulness, it confirms the promi-
nent role pharmaceutical industry as the main source of
information in resource- limited settings and this is of concern as
drug promotions in these settings may not always be content-
directed or evidence-based [14]. By contrast, AB guidelines and in
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particular WHO guidelines were used less frequently. As expected
university courses were significantly more a source of information
for medical students than for medical doctors, and this highlights
the potential role of university education as a forum for
interventions in AB prescribing. In contrast to earlier studies in
middle income countries [9], it is important to note that the
internet resources were used by less than half of the respondents.
This is probably related to the limited access in the country and –
as indicated by the difference between use by students versus
medical doctors – by economic constraints of access. Future
interventions in this setting should acknowledge this and
interactive classic face-to-face trainings might be more effective
and feasible than e-learning tools in this specific setting.
Factors that Drive Prescription Practices
Patient pressure was reported as major factor for AB
prescription in the DRC although significantly less in the hospital
compared to the community setting. In the Peru survey, patient’s
demand was even stronger perceived as a thriving factor with
more than 70% in the community setting and 50% in the hospital
setting. [9].The differences in the overall perception of patient
demand as a thriving factor for prescription between the two study
sites may be explained in part by the lower economic status of
most inhabitants in the Kisangani region. Patients’ demand has
been shown to fuel over-prescription especially for URTI in
resource rich settings too [15,16] but may be perceived stronger by
the prescribing doctor than actually expressed by the patient
[17,18,19].
The fact that local AB resistance patterns and the cause of
infection rather than the availability of AB were scored as
important to the majority of respondents is promising in regard to
future interventions. Most of concern however was that more than
a quarter of respondents did not contest the statement that
unnecessary AB are not of harm to the patient.
AB coming through the national central procurement office
[20] were perceived to be of better quality than those available in
the local pharmacies. However more than 20% of respondents
perceived their quality as not sufficient and 40% did not have an
opinion, highlighting the need for quality assurance of drugs and
communication to professionals and general public in order to
increase confidence.
Acceptability of and Tracks Potential Interventions
In line with the demand for local AB resistance rates, nearly all
respondents welcomed local AB guidelines. AB committees are not
yet functioning in DR Congo and this was apparent from the
absence of opinions about this topic.
Future Research and Interventions
The present study shed a light on the AB prescribing behavior
by medical doctors and students in resource-limited settings in
Central Africa. In order to understand the whole extent of
inappropriate AB prescribing and usage, further research is
needed among the other channels of AB prescribing and
procurement, as well as from private dispensers and the general
public. Differences between the results of previous surveys in other
countries [4,5,6,7,8,9] may advise for campaigns to address the
global problem of antibiotic resistance on a local level. From the
present survey, potential fields of intervention are the following:
improvement of knowledge about AB properties and usage
targeting medical students during their university curriculum,
the provision of unbiased and evidence based information about
AB and local AB resistance rates to all prescribers and the
implementation of quality assurance for drugs in order to improve
confidence among the general public and professionals. Educa-
tional measures such as trainings are highly welcomed, and the
implementation of AB committees should be studied at national
pilot settings.
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